Caffeine and Gad - a phase IV clinical study of FDA data
Summary:
We study 37,928 people who take Caffeine (caffeine) or have Gad. No report of Gad is found in people who take Caffeine.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What is Caffeine?
Caffeine has active ingredients of caffeine. It is often used in fatigue. eHealthMe is studying from 6,665 Caffeine users. Check the latest studies of Caffeine.
What is Gad?
Gad is found to be associated with 828 drugs and 1,479 conditions by eHealthMe. Check the latest studies of Gad.
No report is found.
Do you take Caffeine and have Gad?
- Check whether Gad is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Caffeine:
- Caffeine (6,665 reports)
Gad treatments and more:
- Gad (31,263 reports)
How severe was Gad and when was it recovered:
Expand to all the drugs that have ingredients of caffeine:
- Gad and drugs with ingredients of caffeine (1 reports)
Browse all side effects of Caffeine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Gad:
Browse all the conditions that are associated with Gad:
How the study uses the data?
The study uses data from the FDA. It is based on caffeine (the active ingredients of Caffeine) and Caffeine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Blood Glucose Abnormal and Abdominal Pain - 9 seconds ago
- Omeprazole and Prolia drug interactions for women aged 40-49 - 10 seconds ago
- Narcolepsy and drugs of ingredients of amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate - 29 seconds ago
- Fish Oil and Taste - Impaired for Men aged 50-59 - 40 seconds ago
- Ipratropium Bromide and High Blood Sugar for Men aged 60+ - 41 seconds ago
- Fish Oil and Loss Of Taste for Men aged 50-59 - 41 seconds ago
- Ipratropium Bromide and Hyperglycaemia for Men aged 60+ - 41 seconds ago
- Fish Oil and Dysgeusia for Men aged 50-59 - 41 seconds ago
- Ipratropium Bromide and High Blood Glucose Level for Men aged 60+ - 42 seconds ago
- Fish Oil and Metallic Taste for Men aged 50-59 - 42 seconds ago